Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol KIR2DS2 contributors: mct/npt - updated : 30-04-2010
HGNC name killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 2
HGNC id 6334
DNA
TYPE functioning gene
SPECIAL FEATURE component of a cluster
text natural killer cell receptor cluster FLNKR@
STRUCTURE 14.30 kb     8 Exon(s)
MAPPING cloned Y linked N status confirmed
RNA
TRANSCRIPTS type messenger
text alternatively spliced (truncated) forms,NKAT5 del Ig1,Ig1/Ig2 (Dohring 1996)
identificationnb exonstypebpproduct
ProteinkDaAAspecific expressionYearPubmed
8 splicing 1559 - 304 - Dohring (1996)
- splicing 1123 - 204 - Dohring (1996)
also called NKAT5 delta Ig1
- splicing 1129 - 206 - Dohring (1996)
also called NKAT5 deltaIg1/Ig2
EXPRESSION
Type
constitutive of
   expressed in (based on citations)
organ(s)
tissue
SystemTissueTissue level 1Tissue level 2LevelPubmedSpeciesStageRna symbol
Blood / Hematopoietic    
cells
SystemCellPubmedSpeciesStageRna symbol
Blood/Hematopoieticleukocyte
cell lineage
cell lines
fluid/secretion
at STAGE
PROTEIN
PHYSICAL PROPERTIES
STRUCTURE
motifs/domains
  • two Ig extracellular domains
  • a short cytoplasmic tail
  • HOMOLOGY
    Homologene
    FAMILY
  • immunoglobulin superfamily
  • natural killer cell receptors family
  • CATEGORY immunity/defense , receptor membrane
    SUBCELLULAR LOCALIZATION     plasma membrane
    text type 1 membrane protein
    basic FUNCTION
  • may be functioning as a receptor for class I molecules on NK cells
  • may be activating NK cell activity
  • CELLULAR PROCESS
    PHYSIOLOGICAL PROCESS immunity/defense
    PATHWAY
    metabolism
    signaling
    a component
    INTERACTION
    DNA
    RNA
    small molecule
    protein
    cell & other
    REGULATION
    ASSOCIATED DISORDERS
    corresponding disease(s)
    Susceptibility
  • to systemic sclerosis (SSc)
  • to systemic lupus erythematosus (Pellett 2007)
  • Variant & Polymorphism other association of the combination KIR2DS2(+)/KIR2DL2(-) with increased risk for SSc (Salim 2010)
    Candidate gene
    Marker
    Therapy target
    ANIMAL & CELL MODELS